Abstract
In the past, we generated transgenic mice that overexpress the human histamine 2 (H2)-receptor (H2-TG) or that overexpress the human serotonin 4 (5-HT4)-receptor (5-HT4-TG) in the heart. Here, we crossbred these lines of mice to generate double transgenic mice that overexpress both receptors (DT). This was done to study a conceivable interaction between these receptors in the mouse heart as a model for the human heart. When in left atria, initially, force of contraction was elevated maximally with 1 µM serotonin, and subsequently, histamine was cumulatively applied; a biphasic effect of histamine was noted: the force of contraction initially decreased, maximally at 10 nM histamine, and thereafter, the force of contraction increased again at 1 µM histamine. Notably, functional interaction between 5-HT and histamine was also identified in isolated electrically stimulated trabeculae carneae from human right atrium (obtained during cardiac surgery). These functional and biochemical data together are consistent with a joint overexpression of inotropically active H2-receptors and 5-HT4-receptors in the same mouse heart. We also describe an antagonistic interaction on the force of contraction of both receptors in the mouse atrium (DT) and in the human atrial muscle strips. We speculate that via this interaction, histamine might act as a “brake” on the cardiac actions of 5-HT via inhibitory GTP-binding proteins acting on the activity of adenylyl cyclase.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Cardiac contractile effects of histamine in man are explained by a direct activation of histamine receptors in cardiac cells of the heart. Four different G-protein coupled heptahelical histamine receptors, the H1-, H2-, H3-, and H4-histamine receptors, have been described (Jutel et al. 2009). The H1-, H3-, and H4-receptors can stimulate the enzymatic activity of phospholipase C (PLC) and/or can inhibit adenylyl cyclase activity (review: Panula et al. 2015), whereas the H2-receptors can activate adenylyl cyclase activity (human heart: Klein and Levey 1971, Bristow et. al. 1982a, b). Histamine shows regional functional differences with respect to force generation (atrium vs. ventricle) and species differences in its cardiac actions.
For instance, in the rabbit atrium and ventricle, the H1- and H2-receptors are both expressed at the RNA and protein levels. In the rabbit heart, H2-receptors mediate the positive inotropic and chronotropic effects of histamine in atria, whereas H1-receptors are predominantly involved in the positive inotropic effect of histamine in ventricles (Hattori et al. 1988, 1990, 1991). Likewise, in humans, the H1- and H2-histamine receptors were detected several decades ago in the atrium and ventricle (radioligand binding: Baumann et al. 1982, 1983, 1984, antibody and mRNA expression: Matsuda et al. 2004). In humans, the cardiac H2-receptors were thought to mediate the PIE and PCE of exogenously applied histamine in isolated human cardiac preparations (atrium: Levi et al. 1981, Genovese et al. 1988, Zerkowski et al. 1993, Sanders et al. 1996, ventricle: Ginsburg et al. 1980). The PIE of histamine in the human heart was accompanied (and hence probably mediated) by an increase in the 3′,5′-cyclic adenosine monophosphate (cAMP) content, by activation of cAMP-dependent protein kinase (PKA, human right atrial preparations: Sanders et al. 1996), and by an increased current through L-type Ca2+ channels (ventricle: Eckel et al. 1982, compare scheme in Fig. 1); these responses then led to an increase in the phosphorylation state of phospholamban (Gergs et al. 2019a). Hence, the mode of action of H2-receptors in the human heart mimics that of the β-adrenoceptor system.
Moreover, isolated preparations from human atria show a PIE and a relaxant (or lusitropic) effect when treated with serotonin (5-HT) (Kaumann, 1990; Kaumann and Sanders, 1994; Sanders and Kaumann 1992). Under normal conditions, 5-HT is stored in thrombocytes, so the heart receives 5-HT from the blood (Verbeuren 1990; 1992). In the past, we presented evidence that 5-HT and histamine can also be produced by and found in considerable amounts in isolated cardiomyocytes (Neumann et al. 2021, Pönicke et al. 2012). The cardiovascular effects of 5-HT have been reviewed in detail elsewhere (Kaumann and Levy, 2006, Neumann et al. 2017).
The PIE response to 5-HT includes an increase in cAMP-content and an increase in the activity of protein kinase A (PKA). In addition, in cardiomyocytes from human heart, 5-HT treatment increased the currents through L-type Ca2+-channels due to increased channel availability (Jahnel et al. 1992, 1993) and the phosphorylation state of phospholamban (Gergs et al. 2009). The lusitropic cardiac effects of cAMP-increasing drugs like 5-HT are usually explained by this phospholamban phosphorylation. The reversal of the PIEs of 5-HT in human cardiac preparations by specific 5-HT4 antagonists led to the conclusion that those PIEs were mediated by 5-HT4 receptors (Sanders et al., 1995).
In isolated pig heart preparations and in anaesthetized pigs, 5-HT has shown a positive chronotropic effect (Kaumann 1990; Villalón et al. 1990). This porcine effect was also classified as 5-HT4-receptor-mediated, based on antagonist studies (Kaumann 1990). Interestingly, the pig seems to be the only species besides man that exhibits a PIE and a PCE that is induced by 5-HT activation of 5-HT4-receptors (Kaumann 1990). Other animal species show PIE or PCE in response to 5-HT, but their effects are not mediated by 5-HT4-receptors but via a release of endogenous noradrenaline (overview: Kaumann and Levy 2006, Neumann et al. 2017). In the rabbit heart, serotonin is not only taken up into cardiac sympathetic nerves and releases noradrenaline from the storage sites but also acts as an endogenous β-adrenoceptor antagonist (Hattori et al. 1992).
The PIE of histamine is mediated by H1-receptors in the porcine ventricle, whereas the PIE of histamine in human ventricles is mainly mediated by H2-receptors (Du et al. 1993). Hence, an animal model that expresses both functional human 5-HT4-receptors and human H2-receptors in the ventricle and the atrium is currently lacking and would be a relevant and a convenient model for preparations from the human myocardium. The aim of this study was to develop this type of model.
Isolated mouse (WT; wild-type = non-transgenic) cardiac preparations show no response to 5-HT or histamine (with regard to inotropy and chronotropy), presumably because of the lack of receptor protein expression or lack of effector coupling (Gergs et al. 2010, 2013, 2019a). We have generated suitable models for these human receptors in our previous studies by producing transgenic mice that overexpress the human 5-HT4a receptor (5-HT4-TG) or the human H2 receptor (H2-TG mice) only in the heart by means of a cardiac-specific promoter sequence. In these 5-HT4-TG hearts (but not in WT hearts), 5-HT exerts both a PIE and a PCE (Gergs et al. 2010, 2013), while in the H2-TG mice, histamine exerts a PIE and a PCE (Gergs et al. 2019a, 2020).
The present study was initiated to determine whether the inotropic and chronotropic effects of histamine and serotonin are detectable and show functional contractile activity in intact heart, isolated hearts and cardiac atrial preparation from double transgenic (DT) mice engineered to express both the human H2-receptor and the 5-HT4-receptor, as in the human heart. A second aim was to determine whether interactions occurred between 5-HT and histamine with respect inotropy occur in DT and to ask whether the same interactions are also detectable in the human heart and might therefore have clinical relevance.
Parts of this investigation have been published before in abstract form (Schwarzer et al. 2019; Neumann et al. 2019).
Materials and methods
Transgenic mice
Transgenic mice (TG) with cardiac myocyte-specific overexpression of the human 5-HT4 receptor or the H2 receptors and their littermate control mice (WT) were generated as described by Gergs et al. (2010, 2019a). Both lines were crossbred to obtain double transgenic mice (DT). Heart-specific expression was achieved via the α-myosin heavy-chain promoter. The age of the animals ranged from three to five months. Animals were handled and maintained according to approved protocols of the animal welfare committee of the University of Halle-Wittenberg, Halle.
Contractile studies in mice
In brief, mice were sacrificed, the thorax was opened, the heart was mobilized and cut from the ascending aorta to make sure the right atrium was not damaged. Then, the whole heart was transferred to a dissection chamber filled with gassed Tyrode’s solution at room temperature. Right or left atrial preparations were isolated and mounted in organ baths at 37 °C with a as described by Gergs et al. (2013, 2017, 2019b) and Neumann et al. (2003). The atrial preparations were stimulated by rectangular pulses (5 ms duration and voltage 10% of threshold) of 1 Hz frequency. The right atrial preparations were allowed to beat spontaneously. Force was detected under isometric conditions, amplified and fed into a digitizer and quantified by a commercial software (Chart 5, Adistruments, Oxford, United Kingdom).
Contraction studies in human atrium
This was performed as reported repeatedly, e.g., by Gergs et al. (2009). In brief, during cardiac surgery, at the site where the cannula for extracorporeal circulation entered the heart, small muscle strips were obtained from the right atrium. Patients were aged between 48 and 72 years and their written informed consent was obtained for the use of their right atrial tissues prior to undergoing cardiac surgery. Medication included acetylsalicylic acid, nitrates, diuretics, β-adrenoceptor blockers and anticoagulants. Trabeculae were dissected and mounted in organ baths and electrically stimulated (1 Hz) (5 ms duration and voltage 10% of threshold) at 37 °C and force recordings were processed like in mouse atrial preparations.
Western blotting
The processes of sample homogenization, protein concentration measurement, electrophoresis, antibody incubation and signal quantification were performed following our previously published protocols (Gergs et al. 2009, 2019a, 2019b; Boknik et al. 2018). In the past, we it was necessary to prepare membranes enriched in the sarcoplasmic reticulum to detect phospholamban (PLB) and its phosphorylation state in radioactively labeled isolated hearts (for example: Neumann et al. 1993). More recently, an antibody against phosphorylated PLB has become commercially available, where one does not need to prepare membranes in atrial or ventricular preparations but where cardiac homogenates are sufficient (for example: Gergs et al. 2009).
Electrophoresis was performed in Novex™ 4–12% “Tris–Glycine Plus Midi Protein Gels” (Invitrogen, Thermo Fisher Scientific, Waltham, Massachusetts, USA), The run was performed at 4 °C for approximately 1 h at 120 V in the “NuPAGE MES SDS Running Buffer” (Thermo Fisher Scientific, Waltham, Massachusetts, USA) using the Bio-Rad system (Bio-Rad Laboratories, Hercules, California, USA). Protein transfer into membranes (Amersham™ Protran, GE Healthcare, Chicago, IL, USA) was performed at 2 A for 2 h at 4 °C. Membrane blocking for 1 h at room temperature was followed by overnight incubation at 4 °C with the primary antibody for serine 16—phosphorylated phospholamban (catalogue number: A010-12AP; PLB Ser16, Badrilla, Leeds, UK), while calsequestrin antibody (CSQ2) was used as loading control (product number: ab3516; abcam, Cambridge, UK). Visualization of the signal was performed by using enhanced chemifluorescence staining (“ECF™ Substrate for Western Blotting,” Amersham, GE Healthcare, Chicago, IL, USA) and a Typhoon 9410 Imager (GE Healthcare, Chicago, IL, USA). Quantification was performed using ImageQuant TL image analysis software (GE Healthcare, Chicago, IL, USA).
Echocardiography
Echocardiography was performed as published previously (Boknik et al. 2019, Gergs et al. 2018). After induction of anaesthesia by isoflurane (Forene®, AbbVie, North Chicago, IL, USA), 100 µl of 1 mM 5-HT solution (5-hydroxytryptamine (serotonin) hydrochloride, Lot. 121K7059, Sigma-Aldrich Chemie GmbH, Germany) or the same volume of a 1 mM solution of histamine (histamine dihydrochloride, EC No. 2002984, Fluka BioChemika, St. Gallen, Switzerland) were injected. Cardiac left ventricles were visualized using the Vevo 2100 Linear Imaging System (VisualSonics Inc., Toronto, Ontario, Canada).
Real-time polymerase chain reaction
Real-time polymerase chain reaction (PCR) analysis was performed as described previously (Gergs et al., 2019a, b, c). Total RNA from cardiac ventricular samples was isolated by phenol/chloroform extraction (TRI Reagent®, Cat. 15,596,026, Invitrogen, Thermo Fisher Scientific, Waltham, Massachusetts, USA) and transcribed into cDNA via “Maxima First Strand cDNA Synthesis Kit” (Lot. 00,959,956, Thermo Fisher Scientific, Waltham, Massachusetts, USA). Real-time PCR (Bio-Rad CFX Connect cycler, Bio-Rad Laboratories, Hercules, California, USA) was performed using “iTag Universal SYBR Green Supermix” (Cat. 1,725,121, Bio-Rad Laboratories, Hercules, California, USA). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a reference gene for calculations of target gene expressions, namely human and mouse 5-HT4- and H2-receptors (for primer sequences see Table 3). Relative expression of mRNA was calculated by 2−∆∆Ct method (Livak and Schmittgen, 2001).
Langendorff perfusion
Hearts were isolated and retrogradely perfused in a custom made glass perfusion system at 37 °C following our own procedures (Gergs et al. 2010, 2017, 2019b). Force was measured under isometric conditions from the apex cordis, amplified and digitized. At the peak of the contractile effects (5 min), whole hearts were shock frozen with aluminum clamps (Wollenberger clamps) previously cooled in liquid nitrogen and kept at -80 °C until further analysis.
Data analysis
Data were treated as in most our previous studies (e.g. Gergs et al. 2019a, b, c). Shown are means ± standard error of the mean. Statistical significance was estimated by analysis of variance followed by Bonferroni’s t-test. A P-value of less than 0.05 was considered significant. Experimental data for agonist-induced positive inotropic and chronotropic effects were analyzed by fitting sigmoidal curves to the experimental data with GraphPad Prism 5.0. All other statistical analyses were performed as indicated in the figures and tables.
Drugs and materials
(-)-Isoprenaline ( +)-bitartrate, histamine dihydrochloride, and serotonin hydrochloride were purchased from Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany). All other chemicals were of the highest purity grade commercially available. Deionized water was used throughout the experiments. Stock solutions were freshly prepared daily.
Results
Left atrial preparations
As seen in the original recordings (Fig. 2) and summarized in Fig. 3, histamine elicited a concentration-dependent PIE in isolated electrically stimulated (1 Hz) left atrial preparations from DT and H2-TG mice (Table 1), but histamine did not elicit a PIE in WT and 5-HT4-TG preparations (Figs. 2, 3A, B, and C). Likewise, histamine increased the absolute values of the dF/dtmax and dF/dtmin (Fig. 3D) and decreased the time to peak tension (Fig. 3B) and histamine decreased the time of relaxation (Fig. 3C) in H2-TG and DT preparations, but not in 5-HT4-TG and WT preparations. Moreover, if histamine was given initially (see Fig. 2 for design) and the results are compared with the effect of histamine (Fig. 4E–H) given after an initial treatment with 5-HT, the PIEs in the DT and H2-TG preparations, which originally showed very similar effects, were shifted to higher concentrations of histamine: this suggests a desensitization of H2-histamine receptors (Fig. 4B and 4C). More specifically, the potency of histamine was similar in H2-TG and DT in the first effect (Fig. 3A, Table 1). In contrast, the potency of histamine was similar in H2-TG and DT in the second effect (Fig. 4E, Table 1).
As seen in the original recordings (Fig. 2) and summarized in Fig. 4, in the second series of experiments, initially given 5-HT induced a concentration-dependent PIE in isolated electrically stimulated (1 Hz) left atrial preparations from 5-HT4-TG and DT mice (Fig. 4A) (Fig. 2C, Table 1), but 5-HT exerted no contractile effect in WT and H2-TG preparations (Fig. 4A). Likewise, 5-HT increased the absolute values of the dF/dtmax and dF/dtmin (Fig. 4D) and concomitantly decreased the time to peak tension (Fig. 4B) and the time of relaxation (Fig. 4C) in the atrial preparations from H2-TG and DT mice, but not in atrial preparations from 5-HT4-TG and WT mice. Moreover, if 5-HT was given first (see Fig. 2 for design) and the effect was compared with the effect of 5-HT (Fig. 4A) after initial treatment with histamine, the PIE in the DT and H2-TG preparations, which initially occurred at different EC50 values (Fig. 3E), were shifted to similar EC50 values (Table 1). In other words, 5-HT was more potent to increase force of contraction in 5-HT4-TG than in DT when 5-HT was given as the first effect (Fig. 4A, Table 1). In contrast, 5-HT appeared similarly potent in 5-HT4-TG than in DT when 5-HT was added in the second effect (Fig. 3E, Table 1).
Right atrial preparations
Similarly to the observations in left atrial preparations described above, histamine led to a concentration-dependent PCE (Table 1) in right atrial preparations of H2-TG and DT mice, as shown in Fig. 5A, but was ineffective to exert a PCE in WT and in 5-HT4-TG preparations (Fig. 5A). Histamine displayed more potent and maximal effects in naïve atria from H2-TG as compared to DT mice (Fig. 5D). No such difference was observed when the concentration–response curves to histamine were measured after the responses to serotonin had been measured (Fig. 5D).
Similarly, 5-HT elicited a concentration-dependent PCE (Table 1) in right atrial preparations of 5-HT4-TG and DT mice (Fig. 5C), but had no effect in WT preparations (Fig. 5C). When histamine was given first, it was more potent in DT than in 5-HT4-TG preparations for eliciting a PCE (Fig. 5B, Table 1). However, when histamine followed the 5-HT treatment (see Fig. 2 for the design), the potencies were similar (Fig. 5D, Table 1).
Interactions
Having established the DT model, we then used this model to look for interactions between the H2- and 5-HT4-receptors in DT preparations. We first applied 5-HT and again detected a PIE in the left atria (Fig. 6). Thereafter, 5-HT was not washed out as in the experiments reported above, but histamine was additionally applied in the continued presence of 5-HT. We now noted a biphasic effect of histamine: at low concentrations, histamine reduced the force of contraction but at higher concentrations, histamine increased the force of contraction (Fig. 6). The opposite was not the case: in further experiments we first stimulated isolated left atria from DT maximally with 1 µM histamine and then treated the atria in the organ bath with cumulative concentrations of 5-HT. Under these conditions 5-HT (1 nM to 1 µM) failed to decrease force of contraction (n = 5, data not shown).
Human right atrial preparations
We next translated these findings to humans using human right atrial preparations. As in the DT mouse preparations, pre-stimulation with 5-HT, followed by histamine, first showed a reduction in force of contraction (10 nM histamine) and then at higher concentrations of histamine (1–10 µM histamine; Fig. 7A–D) an increase in force of contraction ensued.
M-mode echocardiography of mice
Similar to our data on the isolated atrium, histamine increased the ejection fraction (EF), an established measurement of left ventricular contractility in living animals, in narcotized H2-TG and in narcotized DT mice, but not in narcotized 5-HT-TG and in narcotized WT mice. Likewise, 5-HT increased the EF in narcotized 5-HT-TG and narcotized DT mice (Fig. 8).
Isolated perfused heart according to Langendorff
Analogous to our data on isolated atrium, histamine increased the beating rate and the left ventricular force of contraction and raised the absolute values of the rate of tension development (dF/dt) in Langendorff-perfused H2-TG and DT mouse hearts, but not in 5-HT-TG and WT mouse hearts. Likewise, 5-HT increased the beating rate and dF/dtmax in Langendorff-perfused 5-HT-TG and DT mouse hearts, but not in H2-TG and WT mouse hearts. As a control, isoprenaline increased the beating rate and dF/dt in Langendorff-perfused H2-TG, 5-HT4-TG, DT, and WT mouse hearts (Table 2).
Phosphorylation state of phospholamban
Similar to our contractile data from isolated atria and left ventricles (= Langendorff-perfused hearts), histamine increased phospholamban phosphorylation (Fig. 9) on serine 16 in isolated perfused hearts from H2-TG and DT mice, but not from 5-HT-TG and WT mice. Likewise, 5-HT increased phospholamban phosphorylation on serine 16 in ventricles from 5-HT4-TG and DT mice, but not from H2-TG and WT mice (Fig. 9).
Receptor expression
As seen in Fig. 10 (bottom), the transgenic human H2-receptor and the transgenic human 5-HT4-receptors are very highly expressed (compare different scaling of the ordinates in Fig. 10 top and bottom) in H2-TG, or 5-HT-TG and DT. The endogenous mouse 5-HT4-receptor is substantially increased in its expression in 5-HT4-TG and DT. In contrast the expression of mouse H2-receptors is low compared to mouse 5-HT4-receptor and is not significantly different between the genotypes tested here (Fig. 10, top) (Table 3).
Discussion
As expected for the DT mice that overexpress both the 5-HT4- and H2-receptors, 5-HT and histamine elicited a PIE and a PCE. We noticed a mechanical effect in all regions of the heart. For instance, histamine and serotonin (5-HT) stimulated the left atrium and the left ventricular force, as measured in Langendorff-perfused hearts, as well as the left ventricular wall motion in the living animal, as assessed by echocardiography. Likewise, the PCE response to histamine and 5-HT was not only seen in isolated right atria, but also in isolated perfused hearts. Hence, we have succeeded in overexpression in the left atrium, right atrium and left ventricle based on our functional data.
In addition, the signal transduction in DT seems at least consistent with the signal transduction in the human heart: we noted an increase in phospholamban phosphorylation in DT preparations after histamine or 5-HT application. This is consistent with our earlier work, where we measured an elevation of phospholamban phosphorylation in the human heart by histamine via H2-receptors and by 5-HT via 5-HT4-receptors (Gergs et al. 2017, 2009). Increases in phospholamban phosphorylation after application of histamine or 5-HT are also in line with our mechanical findings: it is generally accepted that phospholamban phosphorylation, at least in part, causes an increased rate of tension development and a shortening of the time of relaxation because phosphorylated phospholamban enhances Ca2+ uptake into the sarcoplasmic reticulum (Fig. 1 and Haghighi et al. 2014).
The effects of histamine or 5-HT were also noted in living mice by echocardiography. Hence, we would argue that we have generated a new double transgenic mouse line that is able to recapitulate some effects of histamine and 5-HT that are known to occur in the human heart via active H2 receptors and active 5-HT4 receptors. We successfully expressed the human receptor sequences in our model.
Hence, this mouse model should provide more insights into human receptor pharmacology and allow the testing of hypotheses that can then be confirmed in human isolated cardiac preparations.
Our experiments showed that the order of treatment did not qualitatively matter: if histamine was given first and then 5-HT or whether 5-HT was given first and then histamine, the resulting contractile responses were qualitatively the same. The effects of histamine on force of contraction were superimposable in the DT and H2-TG mice. By contrast, 5-HT elicited a less potent increase in the force of contraction of DT mice than of 5-HT4-TG mice.
Hence, the co-expressed 5-HT4 and H2-receptors could interact in an inhibitory fashion. Dimeric heteromeric G-protein coupled receptors are known to exist, and the dimerization in other receptors leads to loss of potency (Rukavina Mikusic et al. 2020). Conversely, the density of 5-HT4 is lower in 5-HT4-TG than in DT mice (Fig. 9).
We also noticed a heterologous desensitization. We had shown previously that 5-HT shows homologous desensitization in 5-HT4-TG mice (Gergs et al., 2017), but we noted more desensitization in the H2–receptor mediated actions and most in the 5-HT4 receptor-mediated action. Consistent with this explanation, we have reported pronounced homologous desensitization in 5-H4-TG mice and hardly measurable desensitization in H2-TG mice (Gergs et al. 2017, 2019b).
We used the DT mice in the next step to study whether a functional interaction exists between human H2- and human 5-HT4-receptors in the atrium. Somewhat unexpectedly, we noted that when we did not wash out 5-HT (as was done in Fig. 2), the added histamine was not inactive (we had assumed that 5-HT should have activated the force maximally, so a further increase by another cAMP coupling receptor was not expected), as it decreased the force of contraction. We suggest this as the first confirmation of the validity of our DT mice as a model for the human atrium, as we noted exactly the same negative inotropic effect of small concentrations of histamine in the continued presence of maximally active (with respect to contractility) 5-HT in the human atrium. We now speculate that this inhibitory effect of histamine in the human heart may represent a protective mechanism, since 5-HT can reach very high concentrations in the human atrium after thrombosis and has been suggested to maintain or induce cardiac arrhythmias via stimulation of cardiac 5-HT4 receptors (Kaumann and Levy 2006).
Interestingly, previous work has shown that, during stimulation of protein kinase C with phorbol esters, stimulation of β1-adrenoceptors with isoprenaline can inhibit the current through L-type Ca2+ channels stimulated by histamine in guinea pig ventricular cardiomyocytes (Belevych et al. 2004) that express H2 receptors (Verma and McNeill 1977). Similarly, histamine could block the isoprenaline-induced increase in current through L-type Ca2+-channels in guinea pig ventricular cardiomyocytes, and this effect was blocked by H2-blockers (but not H1-blockers: Belevych et al. 2004). This effect was not seen in cardiomyocytes pretreated with pertussis toxin, which is known to functionally block pathways involving inhibitory GTP-binding proteins (Belevych et al. 2004). These researchers suggested that the antagonistic effects of between isoprenaline and histamine might relate to the observation that both couple via stimulatory GTP-binding proteins to adenylyl cyclase as well as via inhibitory GTP-binding proteins to adenylyl cyclase. Indeed, others have reported that histamine can bind to inhibitory GTP-binding proteins (Kilts et al. 2000). This previous work showed that pertussis toxin pretreated human atrial membranes show an increase in the stimulatory action of histamine on adenylyl cyclase activity when compared to samples not previously treated with pertussis toxin (Kilts et al. 2000). We hypothesize that a similar mechanism might also explain the interaction between serotonin acting on 5-HT4 receptors and histamine treatment in DT mice, as 5-HT is also known to bind to inhibitory GTP-binding proteins (Kilts et al. 2000). This is an interesting explanation for the findings of our present study but still needs experimental confirmation. Another explanation for our findings in the human atrium might be found in the work of Levi and colleagues (Guo et al. 1984). They observed interestingly in electrically stimulated but also spontaneously beating right atrial preparations from surgical patients a negative inotropic effect of histamine that was blocked by mepyramine and thus probably mediated by H1-receptors whereas higher concentrations of histamine led to positive inotropic effect that were cimetidine sensitive and thus probably H2-receptor mediated. Thus, future studies might test whether the negative inotropic effect we noted in the presence of serotonin in human atrial preparations might be H1-receptor mediated.
In summary, we demonstrate for the first time the possibility of functionally co-overexpressing human H2- and human 5-HT4-receptors in the same mouse heart. We noted an inhibitory interaction between histamine and 5-HT in DT mouse hearts as well as in human atrial muscle strips. We speculate that this interaction can dampen the detrimental effects (like arrhythmias) of 5-HT in human hearts and may act as a brake on the cardiac actions of 5-HT under pathophysiological conditions.
Change history
10 March 2022
The original version of this paper was updated to add the missing compact agreement Open Access funding note.
05 November 2021
A Correction to this paper has been published: https://doi.org/10.1007/s00210-021-02167-2
References
Baumann G, Felix SB, Riess G, Loher U, Ludwig L, Blömer H (1982) Effective stimulation of cardiac contractility and myocardial metabolism by impromidine and dimaprit–two new H2-agonistic compounds–in the surviving, catecholamine-insensitive myocardium after coronary occlusion. J Cardiovasc Pharmaco 4(4):542–553
Baumann G, Mercader D, Busch U, Felix SB, Loher U, Ludwig L, Sebening H, Heidecke CD, Hagl S, Sebening F, Blömer H (1983) Effects of the H2-receptor agonist impromidine in human myocardium from patients with heart failure due to mitral and aortic valve disease. J Cardiovasc Pharmacol 5(4):618–625
Baumann G, Permanetter B, Wirtzfeld A (1984) Possible value of H2-receptor agonists for treatment of catecholamine-insensitive congestive heart failure. Pharmacol Ther 24(2):165–177
Belevych AE, Juranek I, Harvey RD (2004) Protein kinase C regulates functional coupling of beta1-adrenergic receptors to Gi/o-mediated responses in cardiac myocytes. FASEB J 18(2):367–369
Boknik P, Drzewiecki K, Eskandar J, Gergs U, Grote-Wessels S, Fabritz L, Kirchhof P, Müller FU, Stümpel F, Schmitz W, Zimmermann N, Kirchhefer U, Neumann J (2018) Phenotyping of mice with heart specific overexpression of A2A-adenosine receptors: evidence for cardioprotective effects of A2A-adenosine receptors. Front Pharmacol 9:13
Boknik P, Drzewiecki K, Eskandar J, Gergs U, Hofmann B, Treede H, Grote-Wessels S, Fabritz L, Kirchhof P, Fortmüller L, Müller FU, Schmitz W, Zimmermann N, Kirchhefer U, Neumann J (2019) Evidence for arrhythmogenic effects of A2A-adenosine receptors. Front Pharmacol 10:1051
Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB (1982a) Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 307(4):205–211
Bristow MR, Cubicciotti R, Ginsburg R, Stinson EB, Johnson C (1982b) Histamine-mediated adenylate cyclase stimulation in human myocardium. Mol Pharmacol 21(3):671–679
Du XY, Schoemaker RG, X462P6, Bos E, Saxena PR (1993) Effects of histamine on porcine isolated myocardium: differentiation from effects on human tissue. J Cardiovasc Pharmacol. 22(3):468-73. doi: https://doi.org/10.1097/00005344-199309000-00019
Eckel L, Gristwood RW, Nawrath H, Owen DA, Satter P (1982) Inotropic and electrophysiological effects of histamine on human ventricular heart muscle. J Physiol 330:111–123
Galindo-Tovar A, Vargas ML, Escudero E, Kaumann AJ (2009) Ontogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT(4) receptors. Br J Pharmacol 156(2):237–249. https://doi.org/10.1111/j.1476-5381.2008.00023.x
Genovese A, Gross SS, Sakuma I, Levi R (1988) Adenosine promotes histamine H1-mediated negative chronotropic and inotropic effects on human atrial myocardium. J Pharmacol Exp Ther 247(3):844–849
Gergs U, Jahn T, Werner F et al (2019) Overexpression of protein phosphatase 5 in the mouse heart: Reduced contractility but increased stress tolerance-two sides of the same coin? PLoS One. 14(8):e0221289. https://doi.org/10.1371/journal.pone.0221289
Gergs U, Neumann J, Simm A, Silber RE, Remmers FO, Läer S (2009) Phosphorylation of phospholamban and troponin I through 5-HT4-receptors in the isolated human atrium. Naunyn Schmiedebergs Arch Pharmacol 379(4):349–359. https://doi.org/10.1007/s00210-008-0371-y
Gergs U, Baumann M, Böckler A, Buchwalow IB, Ebelt H, Fabritz L, Günther S, Hauptmann S, Kirchhof P, Klöckner U, Pönicke K, Rückschloß U, Schmitz W, Schulz N, Werner F, Neumann J (2010) Cardiac overexpression of the human 5-HT4-receptor in mice. Am J Physiol Heart Circ Physiol 299(3):H788–H798. https://doi.org/10.1152/ajpheart.00691.2009
Gergs U, Böckler A, Ebelt H, Hauptmann S, Keller N, Otto V, Pönicke K, Schmitz W, Neumann J (2013) Human 5-HT4-receptor stimulation in atria of transgenic mice. Naunyn Schmiedebergs Arch Pharmacol 386(5):357–367. https://doi.org/10.1007/s00210-013-0831-x
Gergs U, Fritsche J, Fabian S, Christ J, Neumann J (2017) Desensitization of the human 5-HT4 receptor in isolated atria of transgenic mice. Naunyn Schmiedebergs Arch Pharmacol 390(10):987–996. https://doi.org/10.1007/s00210-017-1403-2
Gergs U, Trapp T, Bushnaq H, Simm A, Silber RE, Neumann J (2019a) Age-dependent protein expression of serine-/threonine-phosphatases and their inhibitors in the human cardiac atrium. Advances in Medicine, 2019, 2675972, 9, 2019. https://doi.org/10.1155/2019/2675972
Gergs U, Bernhardt G, Buchwalow IB, Edler H, Fröba J, Keller M, Kirchhefer U, Köhler F, Mißlinger N, Wache H, Neumann J (2019c) Initial characterization of transgenic mice overexpressing human histamine H2 receptors. J Pharmacol Exp Ther 369:129–141
Gergs U, Kirchhefer U, Bergmann F, Künstler B, Mißlinger N, Au B, Mahnkopf M, Wache H, Neumann J (2020) Characterization of stressed transgenic mice overexpressing H2-histamine-receptors. J Pharmacol Exp Ther 374:479–488. https://doi.org/10.1124/jpet.120.000063.
Ginsburg R, Bristow MR, Stinson EB, Harrison DC (1980) Histamine receptors in the human heart. Life Sci 26(26):2245–2249
Guo ZG, Levi R, Graver LM, Robertson DA, Gay WA Jr (1984) Inotropic effects of histamine in human myocardium: differentiation between positive and negative components. J Cardiovasc Pharmacol. 6(6):1210–5
Hattori Y, Sakuma I, Kanno M (1988) Differential effects of histamine mediated by histamine H1- and H2-receptors on contractility, spontaneous rate and cyclic nucleotides in the rabbit heart. Eur J Pharmacol 153(2–3):221–9
Hattori Y, Nakaya H, Endou M, Kanno M (1990) Inotropic, electrophysiological and biochemical responses to histamine in rabbit papillary muscles: evidence for coexistence of H1- and H2-receptors. J Pharmacol Exp Ther 253(1):250–256
Hattori Y, Gando S, Endou M, Kanno M (1991) Characterization of histamine receptors modulating inotropic and biochemical activities in rabbit left atria. Eur J Pharmacol 196(1):29–36
Hattori Y, Endou M, Kanno M (1992) Inhibition by 5-hydroxytryptamine of the beta adrenoceptor-mediated positive inotropic responses to catecholamines in rabbit papillary muscles: direct interaction with beta adrenoceptors. J Pharmacol Exp Ther 261(3):1160–1166 (PMID: 1318372)
Jahnel U, Rupp J, Ertl R, Nawrath H (1992) Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle. Naunyn Schmiedebergs Arch Pharmacol 346(5):482–485
Jahnel U, Nawrath H, Rupp J, Ochi R (1993 Oct) L-type calcium channel activity in human atrial myocytes as influenced by 5-HT. Naunyn Schmiedebergs Arch Pharmacol 348(4):396–402
Jutel M, Akdis M, Akdis CA (2009) Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy 39(12):1786–1800
Kaumann AJ (1990) Piglet sinoatrial receptors resemble human atrial 5-HT4-like receptors. Naunyn Schmiedebergs Arch Pharmacol 342(5):619–622
Kaumann AJ, Sanders L (1994) 5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic β-adrenoceptor blockade. Naunyn Schmiedebergs Arch Pharmacol 349(4):331–337
Kaumann AJ, Levy FO (2006) 5-hydroxytryptamine receptors in the human cardiovascular system. Pharmacol Ther 111(3):674–706
Kaumann AJ (2011) Phosphodiesterases reduce spontaneous sinoatrial beating but not the ‘fight or flight’ tachycardia elicited by agonists through Gs-protein-coupled receptors. Trends Pharmacol Sci 32(7):377–383. https://doi.org/10.1016/j.tips.2011.03.003
Kilts JD, Gerhardt MA, Richardson MD, Sreeram G, Mackensen GB, Grocott HP, White WD, Davis RD, Newman MF, Reves JG, Schwinn DA, Kwatra MM (2000 ) Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i). Circ Res 87(8):705–709. https://doi.org/10.1161/01.res.87.8.705
Kirchhefer U, Baba HA, Hanske G, Jones LR, Kirchhof P, Schmitz W, Neumann J (2004) Age-dependent biochemical and contractile properties in atrium of transgenic mice overexpressing junctin. Am J Physiol Heart Circ Physiol 287:H2216–H2225. https://doi.org/10.1152/ajpheart.00137.2004
Klein I, Levey GS (1971) Activation of myocardial adenyl cyclase by histamine in guinea pig, cat, and human heart. J Clin Invest 50(5):1012–1015
Levi R, Malm JR, Bowman FO, Rosen MR (1981) The arrhythmogenic actions of histamine on human atrial fibers. Circ Res 49(2):545–550
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 25(4):402–408. https://doi.org/10.1006/meth.2001.1262
Matsuda N, Jesmin S, Takahashi Y, Hatta E, Kobayashi M, Matsuyama K, Kawakami N, Sakuma I, Gando S, Fukui H, Hattori Y, Levi R (2004) Histamine H1 and H2 receptor gene and protein levels are differentially expressed in the hearts of rodents and humans. J Pharmacol Exp Ther 309(2):786–795
Neumann J, Boknik P, Herzig S, Gupta RC, Watanabe AM, Schmitz W, Scholz H (1993) Evidence for physiological functions of protein phosphatases in the heart. Evaluation with okadaic acid. Am J Physiol 265:H257–H266
Neumann J, Boknik P, Matherne GP, Lankford A, Schmitz W (2003) Pertussis toxin sensitive and insensitive effects of adenosine and carbachol in murine atria overexpressing A1–adenosine receptors. Br J Pharmacol 138(1):209–217. https://doi.org/10.1038/sj.bjp.070501
Neumann J, Hofmann B, Gergs U (2017) Production and function of serotonin in cardiac cells. “Serotonin-a chemical messenger between all types of living cells”, Chapter 13; 271–305 ISBN 978–953–51–3361–2 Kaneez Fatima Shad (ed.)
Neumann J, Schwarzer D, Binter M, Gergs U (2019) Interaction of H2-histamine and 5-HT4-serotonin receptors in the mammalian heart and effects of amitryptiline. Inflamm Res 68(Suppl 1):S45
Neumann J, Grobe JM, Weisgut, J, Schwelberger HG, Fogel WA, Wache H, Bähre H, Buchwalow IB, Dhein S, Hofmann B, Kirchhefer U, Gergs U (2021) Histamine can be formed and degraded in the human and mouse heart Front. Pharmacol. https://doi.org/10.3389/fphar.2021.582916
Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WL, Stark H, Thurmond RL, Haas HL (2015) International Union of Basic and Clinical Pharmacology. XCVIII Histamine Receptors Pharmacol Rev 67(3):601–655
Pönicke K, Gergs U, Buchwalow IB, Hauptmann S, Neumann J (2012) On the presence of serotonin in mammalian cardiomyocytes. Mol Cell Biochem 365:301–312. https://doi.org/10.1007/s11010-012-1270-6
Rukavina Mikusic NL, Silva MG, Pineda AM, Gironacci MM (2020) Angiotensin receptors heterodimerization and trafficking: how much do they influence their biological function? Front Pharmacol 11:1179. https://doi.org/10.3389/fphar.2020.01179
Sanders L, Kaumann AJ (1992) A 5-HT4-like receptor in human left atrium. Naunyn Schmiedebergs Arch Pharmacol 345(4):382–386
Sanders L, Lynham JA, Bond B, del Monte F, Harding S, Kaumann AJ (1995 1) Sensitization of human atrial 5-HT4 receptors by chronic β-blocker treatment. Circulation 92(9):2526–2539. https://doi.org/10.1161/01.CIR.92.9.2526
Sanders L, Lynham JA, Kaumann AJ (1996) Chronic beta 1-adrenoceptor blockade sensitises the H1 and H2 receptor systems in human atrium: role of cyclic nucleotides. Naunyn Schmiedebergs Arch Pharmacol 353(6):661–670
Schwarzer D, Gergs U, Neumann J (2019) The effect of histamine and serotonin on transgenic mice co-overexpressing human 5-HT4- and H2-receptors in the heart. Naunyn-Schmiedeberg’s Arch Pharmacol 392(Suppl1):S42
Verbeuren TJ (1990) The distribution and biochemistry of 5-HT in the cardiovascular system. In: Saxena PR, Wallis DI, Wouters W, Bevan P (eds) Cardiovascular Pharmacology of 5-Hydroxytryptamine. Kluwer, Dordrecht, pp 3–13
Verbeuren TJ (1992) 5-Hydroxytryptamine: distribution, synthesis, metabolism, release, uptake, and passage across body membranes in cardiovascular tissues including blood-brain barrier. In: Olsen J, Saxena PR (eds) 5-Hydroxytryptamine mechanisms in primary headache. Raven Press, New York, pp 29–39
Verma SC, McNeill JH (1977) Cardiac histamine receptors: differences between left and right atria and right ventricle. J Pharmacol Exp Ther 200(2):352–362
Villalón CM, den Boer MO, Heiligers JP, Saxena PR (1990) Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor. Br J Pharmacol 100(4):665–667. https://doi.org/10.1111/j.1476-5381.1990.tb14073.x
Vinogradova TM, Lakatta EG (2009) Regulation of basal and reserve cardiac pacemaker function by interactions of cAMP-mediated PKA-dependent Ca2+ cycling with surface membrane channels. J Mol Cell Cardiol 47(4):456–474. https://doi.org/10.1016/j.yjmcc.2009.06.014
Zerkowski HR, Broede A, Kunde K, Hillemann S, Schäfer E, Vogelsang M, Michel MC, Brodde OE (1993) Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium. Naunyn Schmiedebergs Arch Pharmacol 347(4):347–352
Acknowledgements
The work contains parts of the medical thesis of DS and CF. The technical assistance of S. Reber and P. Willmy is gratefully acknowledged. The data were generated in-house and do not come from a paper mill.
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
J.N. designed the research; D.S, C.F, R.S., and M.M. performed the research; D.S., R.S., and U.G. analyzed the data; U.K and BH provided reagents and samples; and U.G. and J.N. wrote and revised the paper. All authors read the manuscript and agreed with its submission.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original version of this article was revised. Figure 7 is now corrected.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Neumann, J., Schwarzer, D., Fehse, C. et al. Functional interaction of H2-receptors and 5HT4-receptors in atrial tissues isolated from double transgenic mice and from human patients. Naunyn-Schmiedeberg's Arch Pharmacol 394, 2401–2418 (2021). https://doi.org/10.1007/s00210-021-02145-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-021-02145-8